SLC6A3 and cervical dystonia: However, the results of the double-blind trial with escitalopram of Zoons et al. showed that a 6-week treatment course with 10 mg escitalopram daily did not influence the DAT binding of [123I]I-FP-CIT in 8 patients with cervical dystonia [95].